SG Fundamental Analysis - SWEETGREEN INC - CLASS A

Fundamental Rating

SG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of SG is average, but there are quite some concerns on its profitability. SG does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SG has reported negative net income.

SG had a positive operating cash flow in the past year.

SG had negative earnings in each of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: SG reported negative operating cash flow in multiple years.

1.2 Ratios

SG has a worse Return On Assets (-13.75%) than 84.96% of its industry peers.

With a Return On Equity value of -28.83%, SG perfoms like the industry average, outperforming 40.60% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-13.75%
ROE	-28.83%
ROIC	N/A

ROA(3y)-14.91%

ROA(5y)-23.59%

ROE(3y)-26.31%

ROE(5y)-34.72%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

SG has a Gross Margin of 26.12%. This is in the lower half of the industry: SG underperforms 78.95% of its industry peers.

In the last couple of years the Gross Margin of SG has remained more or less at the same level.

SG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	26.12%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.09%

GM growth 5Y-0.69%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SG does not have a ROIC to compare to the WACC, probably because it is not profitable.

SG has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, SG has more shares outstanding

There is no outstanding debt for SG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

SG has an Altman-Z score of -0.06. This is a bad value and indicates that SG is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -0.06, SG is doing worse than 84.21% of the companies in the same industry.

SG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-0.06

ROIC/WACCN/A

WACC8.81%

2.3 Liquidity

SG has a Current Ratio of 1.29. This is a normal value and indicates that SG is financially healthy and should not expect problems in meeting its short term obligations.

SG has a better Current ratio (1.29) than 64.66% of its industry peers.

SG has a Quick Ratio of 1.27. This is a normal value and indicates that SG is financially healthy and should not expect problems in meeting its short term obligations.

SG has a Quick ratio of 1.27. This is in the better half of the industry: SG outperforms 67.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.29
Quick Ratio	1.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.97%.

Looking at the last year, SG shows a small growth in Revenue. The Revenue has grown by 2.43% in the last year.

The Revenue has been growing by 19.81% on average over the past years. This is quite good.

EPS 1Y (TTM)-25.97%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-72.22%

Revenue 1Y (TTM)2.43%

Revenue growth 3Y25.81%

Revenue growth 5Y19.81%

Sales Q2Q%-0.6%

3.2 Future

Based on estimates for the next years, SG will show a small growth in Earnings Per Share. The EPS will grow by 5.95% on average per year.

SG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.01% yearly.

EPS Next Y-19.13%

EPS Next 2Y-0.84%

EPS Next 3Y4.53%

EPS Next 5Y5.95%

Revenue Next Year0.95%

Revenue Next 2Y5.95%

Revenue Next 3Y6.86%

Revenue Next 5Y7.01%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SG. In the last year negative earnings were reported.

Also next year SG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-0.84%

EPS Next 3Y4.53%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for SG!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

SWEETGREEN INC - CLASS A

NYSE:SG (12/22/2025, 8:14:14 PM)

Premarket: 6.7 -0.04 (-0.59%)

6.74

-0.11 (-1.61%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Services

GICS IndustryHotels, Restaurants & Leisure

Earnings (Last)11-06 2025-11-06/amc

Earnings (Next)02-26 2026-02-26/amc

Inst Owners89.99%

Inst Owner Change-11.45%

Ins Owners0.9%

Ins Owner Change0.16%

Market Cap797.81M

Revenue(TTM)685.18M

Net Income(TTM)-113.37M

Analysts74.55

Price Target8.39 (24.48%)

Short Float %22.27%

Short Ratio3.67

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-64.32%

Min EPS beat(2)-68.06%

Max EPS beat(2)-60.58%

EPS beat(4)1

Avg EPS beat(4)-33.54%

Min EPS beat(4)-68.06%

Max EPS beat(4)9.26%

EPS beat(8)2

Avg EPS beat(8)-27.1%

EPS beat(12)3

Avg EPS beat(12)-21.07%

EPS beat(16)5

Avg EPS beat(16)-19.5%

Revenue beat(2)0

Avg Revenue beat(2)-6.52%

Min Revenue beat(2)-6.82%

Max Revenue beat(2)-6.23%

Revenue beat(4)0

Avg Revenue beat(4)-4.69%

Min Revenue beat(4)-6.82%

Max Revenue beat(4)-2.2%

Revenue beat(8)1

Avg Revenue beat(8)-3.12%

Revenue beat(12)1

Avg Revenue beat(12)-3.77%

Revenue beat(16)2

Avg Revenue beat(16)-3.16%

PT rev (1m)-28.7%

PT rev (3m)-42.71%

EPS NQ rev (1m)17.45%

EPS NQ rev (3m)-17.99%

EPS NY rev (1m)-14.09%

EPS NY rev (3m)-18.16%

Revenue NQ rev (1m)-0.09%

Revenue NQ rev (3m)-8.33%

Revenue NY rev (1m)-2.83%

Revenue NY rev (3m)-3.6%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.16
P/FCF	N/A
P/OCF	384.12
P/B	2.03
P/tB	2.38
EV/EBITDA	N/A

EPS(TTM)-0.97

EYN/A

EPS(NY)-0.8

Fwd EYN/A

FCF(TTM)-0.92

FCFYN/A

OCF(TTM)0.02

OCFY0.26%

SpS5.79

BVpS3.32

TBVpS2.84

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-13.75%
ROE	-28.83%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	26.12%
FCFM	N/A

ROA(3y)-14.91%

ROA(5y)-23.59%

ROE(3y)-26.31%

ROE(5y)-34.72%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.09%

GM growth 5Y-0.69%

F-Score4

Asset Turnover0.83

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	157.19%
Cap/Sales	16.22%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.29
Quick Ratio	1.27
Altman-Z	-0.06

F-Score4

WACC8.81%

ROIC/WACCN/A

Cap/Depr(3y)172.66%

Cap/Depr(5y)198.17%

Cap/Sales(3y)17.26%

Cap/Sales(5y)20.97%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-25.97%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-72.22%

EPS Next Y-19.13%

EPS Next 2Y-0.84%

EPS Next 3Y4.53%

EPS Next 5Y5.95%

Revenue 1Y (TTM)2.43%

Revenue growth 3Y25.81%

Revenue growth 5Y19.81%

Sales Q2Q%-0.6%

Revenue Next Year0.95%

Revenue Next 2Y5.95%

Revenue Next 3Y6.86%

Revenue Next 5Y7.01%

EBIT growth 1Y-17.02%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year94.38%

EBIT Next 3Y35.83%

EBIT Next 5Y20.5%

FCF growth 1Y4.04%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y235.75%

OCF growth 3YN/A

OCF growth 5YN/A

SWEETGREEN INC - CLASS A / SG FAQ

What is the ChartMill fundamental rating of SWEETGREEN INC - CLASS A (SG) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SG.

What is the valuation status for SG stock?

ChartMill assigns a valuation rating of 0 / 10 to SWEETGREEN INC - CLASS A (SG). This can be considered as Overvalued.

How profitable is SWEETGREEN INC - CLASS A (SG) stock?

SWEETGREEN INC - CLASS A (SG) has a profitability rating of 1 / 10.

Can you provide the financial health for SG stock?

The financial health rating of SWEETGREEN INC - CLASS A (SG) is 5 / 10.

Can you provide the expected EPS growth for SG stock?

The Earnings per Share (EPS) of SWEETGREEN INC - CLASS A (SG) is expected to decline by -19.13% in the next year.

SWEETGREEN INC - CLASS A (SG) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SWEETGREEN INC - CLASS A / SG FAQ

What is the ChartMill fundamental rating of SWEETGREEN INC - CLASS A (SG) stock?

What is the valuation status for SG stock?

How profitable is SWEETGREEN INC - CLASS A (SG) stock?

Can you provide the financial health for SG stock?

Can you provide the expected EPS growth for SG stock?